Cohort information

FRANCE				WP2
Organization		INSERM
Name of cohort		French COVID-19
Referring partner		INSERM
Cohort Information	Country(-ies), cities, regions or centers involved	France
	Time of data collection	02/2020	Ongoing
	Enrolment	Active
	Study setting	Multi-centers
Population	Age	Children,Adolescents,Adults,Elderly
	Type	Both
	Total number of patients	5300
	Site of enrolment (WP2)	Inpatient,ICU
Data collection	Clinical data	True
	Serological data	True
	Genetic data	True
	Sample collection	True
	Sample collected	Whole blood	Yes
		PBMC	No
		Dry-spot blood	No
		Plasma	No
		Serum	No
		Stool	Yes
		NP swabs	Yes
		Other	None
Description	The objectives of this cohort are to describe: 1) clinical features of illness; 2) treatment used and their outcome; 3) virus replication, excretion and evolution in multiple sites; 4) host responses including innate and acquired immune responses; 5) host genetic variants associated with disease progression/severity.